个性化文献订阅>期刊> Journal of controlled release
 

Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: Internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death

  作者 Epstein-Barash, H; Gutman, D; Markovsky, E; Mishan-Eisenberg, G; Koroukhov, N; Szebeni, J; Golomb, G  
  选自 期刊  Journal of controlled release;  卷期  2010年146-2;  页码  182-195  
  关联知识点  
 

[摘要]Partial inactivation and transient depletion of monocytes/macrophages by liposomal bisphosphonates (LIP-Bps) is widely experimented in various inflammatory disorders including restenosis. Previous studies on activation of cytokines by LIP-Bps are limited to certain cell lines. Moreover, the correlation between in vitro and in vivo studies and complement (C) activation has not been reported. We report here a comprehensive study on the bioactivity of LIP-Bps on various cells' internalization and proliferation, mechanism of cell death, cytokines (in vitro and in vivo) and C activation (in the rat, rabbit and pig). The role of the following parameters has been determined i) drug type (clodronate/alendronate); ii) vesicles size (60-800 nm); iii) charge (neutral/negative/positive); and iv) cell culture type (various cell lines and primary cultures). It was found that monocyte/macrophage inhibition and cytokine activation depend on the cell type, with a limited correlation to the bioactivity obtained in the rat and rabbit models of restenosis. Negatively charged liposomes (85 +/- 20 nm) effectively depleted rabbit's monocytes (67% depletion), with a minor activation of cytokines and no C activation. It is concluded that cell culture studies are insufficient for assessing cytokine activation, and that by controlling LIP-BP properties (size, charge and drug type) optimal bioactivity could be achieved. (C) 2010 Elsevier B.V. All rights reserved.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内